NON MUSCLE INVASIVE BLADDER CANCER
Clinical trials for NON MUSCLE INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new NON MUSCLE INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for NON MUSCLE INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New laser technique may improve bladder cancer surgery outcomes
Disease control CompletedThis study compared two surgical techniques for removing early-stage bladder tumors: a new laser method (holmium laser en-bloc resection) and the standard approach (conventional transurethral resection). 100 adults with suspected non-muscle-invasive bladder cancer were randomly a…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New chemo approach may cut bladder cancer return rates
Disease control CompletedThis study tested whether giving a short, intensive course of the chemotherapy drug Mitomycin C before surgery (chemoresection) could lower the chance of bladder cancer coming back, compared to the usual approach of surgery followed by regular chemotherapy instillations into the …
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New surgical technique could cut bladder cancer recurrence
Disease control CompletedThis study compares two surgical methods for removing non-muscle invasive bladder tumors. The new method removes the tumor in one piece, while the standard method removes it in fragments. Researchers want to see if the one-piece approach leads to better tumor removal and fewer re…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New surgical technique may cut bladder cancer recurrence
Disease control CompletedThis study tested two surgical methods for removing early-stage bladder tumors that haven't spread to muscle. One method removes the tumor in one piece (en bloc), while the standard method removes it in multiple pieces. Researchers wanted to see if the one-piece method gives bett…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New bladder cancer drug shows early promise in small trial
Disease control CompletedThis early-phase trial tested a new drug called UGN-301 (zalifrelimab) given directly into the bladder for people with recurrent non-muscle invasive bladder cancer. The study included 51 participants and aimed to check safety and find the right dose, both alone and with other dru…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a pill shrink bladder tumors before surgery?
Disease control CompletedThis phase 2 trial tested pemigatinib, a daily pill that blocks certain growth signals, in 30 people with recurrent low- or intermediate-risk non-muscle invasive bladder cancer. Participants took the drug for 4-6 weeks before their standard surgery to remove bladder tumors. The m…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Pee test vs. scope: which do bladder cancer patients prefer?
Diagnosis CompletedThis study asked 107 people with a history of non-muscle invasive bladder cancer whether they preferred a non-invasive urine test (CxBladder Monitor) or the standard cystoscopy (a thin tube inserted into the bladder) for routine cancer surveillance. Participants tried both method…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New PET scan agent could spot bladder cancer earlier
Diagnosis CompletedThis early-phase study tested a new imaging agent called 89Zr-girentuximab in 6 people with non-muscle-invasive bladder cancer. The goal was to see if it could safely and clearly show tumors on PET/CT scans. Researchers looked for uptake spots in the bladder and checked for side …
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: EARLY_PHASE1 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC